Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Kymriah, Yescarta found ‘cost-effective’ in treating cancer, despite high price
Kymriah, Yescarta found ‘cost-effective’ in treating cancer, despite high price
Kymriah, Yescarta found ‘cost-effective’ in treating cancer, despite high price
Submitted by
admin
on December 21, 2017 - 10:12am
Source:
Endpoints
News Tags:
Kymriah
Yescarta
CAR-T
Novartis
Kite Pharma
Gilead Sciences
drug pricing
Headline:
Kymriah, Yescarta found ‘cost-effective’ in treating cancer, despite high price
Do Not Allow Advertisers to Use My Personal information
